CJC-1295 / Ipamorelin 10mg-20mg

Description

The CJC-1295 / Ipamorelin blend is a synthetic peptide combination designed for in-vitro and preclinical laboratory research applications. This blend pairs CJC-1295, a growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue, to allow researchers to study peptide signaling, receptor interactions, and growth hormone modulation pathways in controlled experimental models.

By combining these peptides, researchers can explore synergistic or comparative activity, stability, and downstream cellular responses under standardized laboratory conditions. The blend is manufactured to high purity standards to ensure consistency, reliability, and reproducibility across research protocols.

This product is intended strictly for scientific research purposes and is not approved for clinical, diagnostic, or therapeutic use.